Immunitybio Inc (IBRX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
8,945,018,000
EV to revenue ratio (TTM)
57.92
EV to ebitda
-8.99
Financial Performance
Revenue (TTM)
165,792,000
Gross profit (TTM)
164,697,000
EBITDA
-235,298,000
Profitability
Operating margin (TTM)
-120.40%
Profit margin
0.00%
Return on assets (TTM)
-30.50%
Return on equity (TTM)
0.00%
Per Share Metrics
Revenue per share (TTM)
0.17
EPS
-0.95
Diluted EPS (TTM)
-0.95
Book value
-0.99
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
123.46
PEG ratio
Price to sales ratio (TTM)
53.95
Price to book ratio (TTM)
Growth
Quarterly earnings growth (YoY)
93.90%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.135